Erosive esophagitis, a complication of chronic gastroesophageal reflux disease (GERD), is documented in 30% to 50% of GERD patients undergoing endoscopy. Current guidelines recommend proton
PPI
PPI
Potassium Competitive Acid Blocker Better Than Proton Pump Inhibitor in Healing Higher Grades of Erosive Esophagitis
Potassium Competitive Acid Blocker Better Than Proton Pump Inhibitor in Healing Higher Grades of Erosive Esophagitis
Wireless pH Monitoring Is Better at 96 Hours Than 48 Hours in Patients With GERD Unresponsive to PPI Therapy
Wireless pH Monitoring Is Better at 96 Hours Than 48 Hours in Patients With GERD Unresponsive to PPI Therapy
A significant portion of patients with reflux-like symptoms do not have GERD and could potentially discontinue proton pump inhibitor (PPI) therapy. Although wireless pH monitoring
Expert Review Advises Personalized Approach to GERD Diagnosis and Treatment
Expert Review Advises Personalized Approach to GERD Diagnosis and Treatment
GERD, manifested by typical symptoms of heartburn as well as regurgitation and additional extraesophageal symptoms, such as chronic cough, sore throat, and globus sensation, affects
Strong Evidence That Long-Term Proton Pump Inhibitor Use Increases Colorectal Cancer Risk
Strong Evidence That Long-Term Proton Pump Inhibitor Use Increases Colorectal Cancer Risk
Data vary regarding whether hypergastrinemia and proton pump inhibitor (PPI) use increase adenoma progression and risk of colorectal cancer (CRC). The current study from the
Are Proton Pump Inhibitors Associated With Increased Mortality?
Are Proton Pump Inhibitors Associated With Increased Mortality?
There has been significant media attention on the risks of proton pump inhibitors (PPIs) noted in observational studies, including associated risks of pneumonia, Clostridium difficile,
Reflux Monitoring Can Reduce the Inappropriate Use of Proton Pump Inhibitors in Patients With GERD
Reflux Monitoring Can Reduce the Inappropriate Use of Proton Pump Inhibitors in Patients With GERD
Proton pump inhibitors (PPIs) are the main treatment for gastroesophageal reflux disease (GERD). However, 30% to 50% of patients with GERD fail to achieve adequate
What Therapy to Use for Patients With EoE: PPIs, Steroids, or Elimination Diets?
What Therapy to Use for Patients With EoE: PPIs, Steroids, or Elimination Diets?
Prateek Sharma, MD, FASGE, reviewing Laserna-Mendieta EJ, et al. Clin Gastroenterol Hepatol 2020 Jan 25. Proton pump inhibitors (PPIs), steroids, elimination diets, and esophageal dilation
